DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

JMP Securities Upgrades Arbutus Biopharma to Market Outperform, Announces $10 Price Target

JMP Securities analyst Liisa Bayko upgrades Arbutus Biopharma (NASDAQ:ABUS) from Market Perform to Market Outperform and announces $10 price target.

Benzinga · 02/05/2020 10:33

JMP Securities analyst Liisa Bayko upgrades Arbutus Biopharma (NASDAQ:ABUS) from Market Perform to Market Outperform and announces $10 price target.